Adult primary paratesticular mesenchymal tumors with emphasis on a case presentation and discussion of spermatic cord leiomyosarcoma by Galosi, Andrea B. et al.
Galosi et al. Diagnostic Pathology 2014, 9:90
http://www.diagnosticpathology.org/content/9/1/90SHORT REPORT Open AccessAdult primary paratesticular mesenchymal tumors
with emphasis on a case presentation and
discussion of spermatic cord leiomyosarcoma
Andrea B Galosi1†, Marina Scarpelli2†, Roberta Mazzucchelli2, Antonio Lopez-Beltran3,4, Lucio Giustini5,
Liang Cheng6 and Rodolfo Montironi2*Abstract
Background: The aim of this report is related to adult primary paratesticular mesenchymal tumors with emphasis
on a case presentation and discussion of the spermatic cord leiomyosarcoma. Primary paratesticular tumors are rare,
only accounting for 7% to 10% of all intrascrotal tumors. In adults, more than 75% of these lesions arise from the
spermatic cord, 20% being leiomyosarcoma. Tumor grade, stage, histologic type, and lymph node involvement are
independently predictive of prognosis.
Findings: The case report concerns a 81-year-old man presented with a 3-year history of painless lump in
the right hemiscrotum. Scrotal examination demonstrated a 5.1-cm, firm-to-hard mass attached to the spermatic cord.
Scrotal ultrasound scan revealed a heterogeneous mass separate from the testis. He was treated with an radical
orchi-funicolectomy. Histologically the lesion is composed of spindled cells with often elongated, blunt-ended nuclei
and variably eosinophilic cytoplasm. Areas with pleomorphic morphology are present. The level of mitotic activity is
equal to 3/10 HPF in the areas with spindle cell morphology and to 12/10 HPF in the areas with pleomorphic
morphology. The final diagnosis was that a leiomyosarcoma of the spermatic cord, with grade 1 and grade 2 areas,
stage pT2b cN0 and cM0. The patient has been followed up for 3 months with CT scans and shows no signs of recurrence.
Conclusions: Spermatic cord leiomyosarcoma, although rare, should be one of the first differential diagnoses for a
firm-to-hard lump in the cord. Apart from radical orchi-funicolectomy, there has been added benefit of adjuvant
radiotherapy to prevent any loco-regional lymph node recurrence.
Virtual Slides: The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/
vs/1613030331125632
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Primary paratesticular mesenchymal tumors
Primary paratesticular tumors are rare, only accounting
for 7% to 10% of all intrascrotal tumors. In adults, more
than 75% of these lesions arise from the spermatic cord
[1-3]. The most frequently reported benign tumors are
hemangiomas, lymphangiomas, leiomyomas and lipomas.* Correspondence: r.montironi@univpm.it
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unless otherwise stated.Male angiomyofibroblastoma-like tumor is a benign
tumor occurring in the scrotum or inguinal region of
older men. Other benign lesions include a variety of nerve
sheath tumors.
Among the malignant tumors, the most common his-
totype is liposarcoma (46.4%), followed by leiomyosar-
coma (LMS) (20%), malignant fibrous histiocytomas
(MFH) (13%), and embryonal rhabdomyosarcoma (9%)
[4]. Liposarcomas and MFH have similar age distribution;
some tumors historically diagnosed as the latter actually
represent dedifferentiated liposarcomas. Liposarcoma and
MFH occur predominantly in older men, 75% of thesetd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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years. Concerning LMS, the peak incidence is in the
sixth and seventh decade. Embryonal rhabdomyosar-
coma is the most common malignant mesenchymal
tumor in children [5,6].
Clinical features
Most scrotal tumors are deep-seated. Benign lesions may
present as slowly enlarging, asymptomatic or mildly un-
comfortable masses. Benign lesions may present as slowly
enlarging, asymptomatic or mildly uncomfortable masses.
In general, malignant tumors are more likely to be symp-
tomatic, large, and have a history of rapid growth. Liposar-
coma is most common, while LMS and MFH histologic
subtypes are observed to be the most aggressive [4].
Tumor grade, stage, histologic type, and lymph node in-
volvement are predictive of prognosis [4,7-9]. Low-grade
LMSs have a good prognosis, whereas high grade tumors
often develop metastases and have a significant tumor-
related mortality. Paratesticular liposarcoma tends to have
a protracted course with common recurrences. Dediffer-
entiation occurs in a minority of cases and also tend to
have a protracted clinical course with local recurrences,
although distant metastases may also occur [10].
Imaging
Liposarcomas generally present as large extratesticular
masses, which are often solid and hyperechoic by ultra-
sound. However, the sonographic appearance of these
tumors is variable and non-specific. CT and MR imaging
are much more specific with fat being easily recognized
with both modalities [11,12]. By CT, fat will appear very
low density similar to subcutaneous fat. On MR imaging
the fat in a liposarcoma will follow the signal intensity of
surrounding fat on all imaging sequences. Additionally a
fat-suppressed imaging sequence should be performed
for confirmation. Fat will lose signal intensity on this se-
quence. Lipomas and hernias containing omentum are
potential mimics, but the former are generally smaller
and more homogeneous, and the latter are elongated
masses, which can be traced back to the inguinal canal.
With the exception of liposarcoma, none of the other
sarcomas can be differentiated from one another radio-
logically. They all tend to be large, complex, solid masses
[11]. Because of their large size, their extent is better
demonstrated by CT and MR imaging rather than ultra-
sound. However, ultrasound is the first exam in the clin-
ical management of all scrotal masses and it has a key
role in the initial management.
Histopathology
Hemangiomas are most common within the scrotum.
Granular cell tumours of the scrotum may be multifocal
and are similar to those elsewhere in the skin. Calcifyingfibrous (pseudo)tumor is a densely collagenous, pauci-
cellullar fibroblastic lesion with focal lymphoplasmacytic
infiltration and scattered psammomatous calcifications.
Great majority of liposarcomas are well-differentiated
with various combinations of lipoma-like and sclerosing
patterns. Multivacuolated lipoblasts may be present, but
are not required for diagnosis. Presence of significant nu-
clear atypia in adipocytes is decisive. Dedifferentiation to
spindle cell “fibrosarcoma-like” or pleomorphic “MFH-
like” phenotype occurs in a proportion of paratesticular
liposarcomas [10]. This component can give rise to metas-
tases. MFH, a pleomorphic fibroblastic-myofibroblastic
sarcoma, is usually diagnosed by exclusion.
Leiomyomas are composed of mature smooth muscle
cells. Focal nuclear atypia may occur, but the presence of
prominent atypia should lead to a careful search for mi-
totic activity or coagulation necrosis which are features of
LMS. LMSs are typically composed of spindled cells with
often elongated, blunt-ended nuclei and variably eosino-
philic cytoplasm. Areas with round cell or pleomorphic
morphology may occur. The level of mitotic activity varies
widely, from <1 mitotic figures per 10 high power fields
(HPF) to >70 mitotic figures per 10 HPF [13].
Findigs
A 81-year-old man presented with a 3-year history of
painless lump in his right hemiscrotum. A scrotal ultra-
sound examination performed approximately two years ago
showed a 2-cm lesion with cystic appearance (Figure 1A)
with intracystic material, close to the head of the epidy-
dimis, and separated from the didimis. A very recent
scrotal examination demonstrated a 5-cm firm-to-hard
mass. The mass had regular surface without any attach-
ment to dartos and surrounding tissues. Ultrasound scan
revealed a heterogeneous mass separate from the didimis
(Figure 1B), close to the epidydimis head, attached to
the spermatic cord. Echo-power-doppler ultrasound re-
veals solid tissue with vascular signals inside the lesion.
The patient underwent radical orchi-funicolectomy fol-
lowing a sub-inguinal approach. The postoperative course
was uneventful. The procedure for this research project
conforms to the provisions of the Declaration of Helsinki.
Consent was obtained from the patient’s next of kin for
the publication of this report.
Macroscopically, the lesion, well circumscribed and
firm, measures 5.1 cm by 4.0 cm and 3.4 cm in the three
diameters. On the cut surface the lesion is whitish in
color with mucoid-like areas (Figures 2 and 3). The le-
sion is separate from the testis and was attached to the
spermatic cord.
Histologically, approximately 80% of the lesion is com-
posed of spindled cells with often elongated, blunt-ended
nuclei and variably eosinophilic cytoplasm (Figure 4). Areas
with pleomorphic morphology are present (Approximately
Figure 1 Scrotal ultrasound. A. 2-cm lesion with cystic appearance
and intracystic material (Arrow), close to the head of the epidydimis,
and separated from the didimis (D). B. Preoperative scrotal untrasound
shows a heterogeneous mass.
Figure 3 Whole mount histological section of the neoplasm
with cystic-like areas containing mucoid-like material.
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ever, cystic-like areas containing mucoid-like material are
present. The level of mitotic activity is equal to 3/10 HPF in
the areas with spindle cell morphology and to 12/10 HPF
in the areas with pleomorphic morphology. The neo-
plasm stains strongly with antibodies to smooth muscle
actin, muscle-specific actin, and desmin (Figure 6). CD34,Figure 2 Gross appearance of the neoplasm. On the cut surface
the lesion is whitish in color with mucoid-like areas.cytokeratin, S-100 protein, MyoD1 and myogenin are
negative. The final diagnosis was that a leiomyosarcoma
of the spermatic cord, with grade 1 and grade 2 areas,
stage pT2b cN0 and cM0. The patient has been followed
up for 3 months with CT scans and shows no signs of
recurrence.
Discussion
Leiomyosarcoma accounts for 5%–10% of soft tissue sar-
coma. Paratesticular LMS originates from the spermatic
cord, the scrotum or the epididymis. The spermatic cord
type arises from undifferentiated mesenchymal cells of
the cremasteric muscle and vas deferens. The epididymalFigure 4 Spindle cell component of the neoplasm.
Figure 5 Pleomorphic area of the neoplasm.
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basement membrane of the epididymis. The scrotal type
arises from the dartous layer. The first two aforemen-
tioned types drain into the retroperitoneal lymph nodes in
contrast with the last type, which drains into the inguinal,
external and internal iliac nodes. LMS is subdivided topo-
graphically into 3 groups: LMS of the deep soft tissue,
LMS of the cutaneous and subcutaneous tissue and LMS
of vascular origin. According to the AJCC Cancer Staging
System, paratesticular LMS should belong to the deep
subtype [14]. Its behavior is related to the site, histological
grade of the lesion and the presence of nodal or distant
metastases.
A recent review of 24 primary paratesticular LMS found
11 tumors in the testicular tunics, 10 in the spermatic
cord, 1 in the scrotal subcutis, 1 in the dartos muscle, and
1 in the epididymis [6]. These were from men aged 34–86
years with a peak incidence in the sixth and seventh dec-
ade [15-20]. In the study by Coleman et al. [8], 22% of the
patients presented with metastatic disease or subsequentlyFigure 6 The neoplasm is intensely immunostained with an
antibody to desmin.developed distant sarcoma. A reported survival rate is
50%–80% [5].
Sonography should be the initial imaging modality since
it can determine the origin of the lesion and even though
the imaging characteristics are not adequate to reach a sin-
gle diagnosis, the heterogeneous appearance along with the
irregular, often increased vascularity of the tumor may
allow the diagnosis of a sarcoma. Correlation with case his-
tory of the patients and CT/MR findings can further limit
the differential diagnosis and lead to a better management
of the patient. The majority of the LMSs are heterogeneous
lesions, although some LMSs appear to be hypoechoic. Cal-
cifications are not mentioned in the majority of the cases
described. Colour Doppler ultrasonography shows either
minimal, or increased vascularity. The appearance is mostly
related to the size of the lesion and the differentiation of
the mesenchymal components. A non-homogeneous mass
with irregular, peripheral contrast enhancement and HU
between 20 and 65, indicative of cystic, solid and calcified
areas were found. A thickened and edematous spermatic
cord with distended vessels was also depicted. The above
CT findings parallel the sonographic ones. In addition to
that, absence of areas with negative HU excluded the pres-
ence of fat within the lesion [21].
The above-mentioned features are pathologically corre-
lated to necrotic areas within the tumor (cystic areas), infil-
tration of the epididymis (epididymis not visualized), origin
from the spermatic cord (high position of the lesion within
the scrotum), absence of testicular infiltration (definite tes-
ticular borders), neoplastic lesions within the spermatic
cord (thick and edematous appearance) and infiltration of
the vessels (vessel distention within the cord)
The morphologic range of LMSs is similar to that re-
ported in other soft tissue sites, including a tumor with
prominent myxoid areas [22], an inflammatory LMS [23],
and a neoplasm with epithelioid foci [24,25]. The majority,
however, display classic features of soft tissue LMS, i.e., per-
pendicularly oriented fascicles of cells with brightly eosino-
philic cytoplasm containing delicate longitudinal fibrils and
blunt-ended nuclei [26,27]. Although some lesions have
numerous pleomorphic nuclei, typical features of smooth
muscle differentiation are retained; even the pleomorphic
nuclei usually remain blunt-ended and paired with
brightly eosinophilic cytoplasm. Pleomorphic LMSs,
however, are composed predominantly of areas resem-
bling malignant fibrous histiocytoma (showing no differ-
entiation) but with focal zones with typical features of
smooth muscle differentiation on hematoxylin and eosin
staining and the appropriate immunophenotype [28,29].
Immunohistochemistry is useful in confirming smooth
muscle differentiation. Most cases stain strongly with
antibodies to smooth muscle actin, muscle-specific actin,
and desmin. Some also stain for CD34. Focal cytokeratin
and S-100 protein positivity may occur, but myogenin
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mas in children can resemble LMSs. However, immuno-
histochemical stains for MyoD1 and myogenin are
positive in the former and negative in the latter.
The NCI grading system identify three grades in LMS
[30,31]. Grade 1 tumors lack necrosis, had <6 mitoses/
10 HPF, and have only occasional pleomorphic nuclei.
Grade 2 tumors have focal necrosis (<15%) and/or mi-
totic activity >6 mitotic figures/10 HPF or prominent
nuclear pleomorphism. The key feature of grade 3 tu-
mors is >15% necrosis, regardless of mitotic counts or
numbers of pleomorphic nuclei. Various studies indicate
the prognostic importance of grading LMSs in this site
because whereas most examples are low grade and be-
have indolently, high-grade lesions are aggressive [6].
High-grade LMSs with pleomorphic nuclei can resemble
dedifferentiated liposarcoma. This can be either identi-
fied by the presence of adjacent foci, which are some-
times very small, of well-differentiated liposarcoma, or
excluded by finding more typical architectural or cyto-
logic features of LMS with further sampling [6,2].
Simple excision is suboptimal as repeat wide excision
has demonstrated microscopic residual disease in 27%
of cases and therefore warrants an additional adjuvant
treatment. Radical orchiectomy and funicolectomy (in-
guinal approach) is the cornerstone of treatment in the
management of this neoplasm, but the reported survival
rates indicate the need for additional treatment [5].
Comprehension of the pattern of spread is essential,
but this task is difficult by the rare occurrence of this
disease. The most common means of dissemination are
by regional lymph nodes spread (external, common iliac,
hypogastric and retroperitoneal lymph nodes), haema-
togenous metastases (most commonly to the lungs) and
by local extension (local infiltration of the scrotum, inguinal
canal or pelvis, along the pathway of vas deferens). Further
series suggested that lymph node dissection (especially
retroperitoneal) should not be performed unless enlarged
lymph nodes are encountered on CT scans or palpated du-
ring surgery.
The literature concerning benefit of adjuvant therapy
after radical surgery is inconclusive because of the small
numbers. Recurrence after orchidectomy alone was com-
mon in earlier reports, and adjuvant radiation has been
recommended to reduce locoregional failure [5].
Due to the high incidence of loco-regional recurrence in
the lymph nodes, 2 different treatment alternatives, prophy-
lactic retroperitoneal lymph node dissection (RPLND) and
radiotherapy, have been tried. The proponents of RPLND
indicate that there is a 29% risk of metastatic potential
to regional lymph nodes. A review of 101 patients by
Banowsky and Schultz described 29 cases of RPLND with
lymph node involvement. Of these, 17 patients had isolated
lymphatic dissemination. Despite such a high incidence oflymphatic spread, no report has yet shown a significant sur-
vival benefit from the addition of RPLND to radical orchid-
ectomy [32]. A study from Massachusetts involved 18
patients who were subdivided into 2 groups of 9 patients.
One group had surgery and the other group had surgery
plus radiation therapy. Of the 9 patients treated with radical
orchidectomy alone, 5 developed loco-regional failure, 2 of
which were limited to lymph nodes. In contrast, there were
no loco-regional recurrences among the 9 patients who re-
ceived adjuvant radiation to the regional lymph nodes [9].
These findings, which are consistent with those of Catton
and colleagues, suggest that adjuvant radiation may effect-
ively control loco-regional microscopic disease [33].
In conclusion, spermatic cord leiomyosarcoma, although
rare, should be included in the list of differential diagnoses
for a firm-to-hard lump in the cord. Apart from radical
orchi-funicolectomy, there has been added benefit of adju-
vant radiotherapy to prevent any loco-regional lymph node
recurrence.
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